Clinical Trial Detail

NCT ID NCT03547115
Title A Phase 1 Study of Voruciclib in Subjects With B-Cell Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors MEI Pharma, Inc.
Indications

marginal zone B-cell lymphoma

CLL/SLL

diffuse large B-cell lymphoma

follicular lymphoma

mantle cell lymphoma

Therapies

Voruciclib

Age Groups: senior adult

No variant requirements are available.